Now loading...
ICICI Securities has upgraded Sun Pharmaceutical Industries to ‘Buy’ with a revised target price of Rs 1895. Sun Pharma, a leading company in the Pharmaceuticals sector, has reported significant income and profit growth. The company’s strategic acquisitions and upcoming drug launches are expected to boost its specialty portfolio, despite a recent stock correction.
Now loading...